Skip to main content
. 2021 Apr 14;10(8):1684. doi: 10.3390/jcm10081684

Table 2.

Outcomes.

Total Patients (n = 47) NPM1mut FLT3-ITDneg
(n = 7)
NPM1mut FLT3-ITDpos
(n = 6)
NPMwt FLT3any
(n = 34)
CCR—no. (%)
CRi/CRp—no. (%)
26 (55%)
13 (50% of all CCR patients)
SD—no. (%) 6 (12%)
PD—no. (%) 15 (32%)
DSF mo (median) 10.6 NR (4.5) (11.5)
EFS mo (median) 4.5 NR (1) (6.4)
OS mo (median) 10.7 NR (2.03) 10.7